Epigenetics Therapeutics to 2017 Now Aavailable at SandlerResearch
GBI Research’s report, “Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma”, provides in-depth analysis of trends, issues and challenges in this industry
View full press release